Cargando…
Multi-Target Approaches in Metabolic Syndrome
Metabolic syndrome (MetS) is a highly prevalent disease cluster worldwide. It requires polypharmacological treatment of the single conditions including type II diabetes, hypertension, and dyslipidemia, as well as the associated comorbidities. The complex treatment regimens with various drugs lead to...
Autores principales: | Lillich, Felix F., Imig, John D., Proschak, Ewgenij |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994619/ https://www.ncbi.nlm.nih.gov/pubmed/33776749 http://dx.doi.org/10.3389/fphar.2020.554961 |
Ejemplares similares
-
In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014) -
Fragment-based identification of multi-target ligands by self-organizing map alignment
por: Achenbach, Janosch, et al.
Publicado: (2012) -
PocketPicker: analysis of ligand binding-sites with shape descriptors
por: Weisel, Martin, et al.
Publicado: (2007) -
Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020) -
Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
por: Göbel, Tamara, et al.
Publicado: (2019)